Anya Rothenbühler

8.8k total citations
83 papers, 1.6k citations indexed

About

Anya Rothenbühler is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Anya Rothenbühler has authored 83 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Nephrology, 29 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Molecular Biology. Recurrent topics in Anya Rothenbühler's work include Parathyroid Disorders and Treatments (34 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Bone health and treatments (14 papers). Anya Rothenbühler is often cited by papers focused on Parathyroid Disorders and Treatments (34 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Bone health and treatments (14 papers). Anya Rothenbühler collaborates with scholars based in France, Italy and United States. Anya Rothenbühler's co-authors include Agnès Linglart, Peter Kamenický, Pierre Bougnères, Karine Briot, Constantine A. Stratakis, Catherine Chaussain, Martin Biosse Duplan, Dominique Prié, Philippe Wicart and Pol Harvengt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anya Rothenbühler

79 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anya Rothenbühler France 23 784 422 407 371 348 83 1.6k
Renata C. Pereira United States 24 774 1.0× 512 1.2× 457 1.1× 116 0.3× 923 2.7× 65 2.0k
Peter Kamenický France 31 1.1k 1.3× 515 1.2× 444 1.1× 1.5k 4.0× 499 1.4× 105 3.1k
Alison Skrinar United States 21 691 0.9× 216 0.5× 272 0.7× 118 0.3× 202 0.6× 50 1.5k
Takuo Kubota Japan 19 230 0.3× 404 1.0× 292 0.7× 307 0.8× 725 2.1× 86 1.5k
Lars Rolighed Denmark 24 826 1.1× 165 0.4× 400 1.0× 330 0.9× 334 1.0× 71 1.7k
R Zahradnik Sweden 8 1.2k 1.5× 440 1.0× 517 1.3× 106 0.3× 314 0.9× 8 1.5k
V. Braga Italy 27 217 0.3× 459 1.1× 827 2.0× 210 0.6× 494 1.4× 54 2.1k
Ewa Lewin Denmark 23 865 1.1× 369 0.9× 174 0.4× 81 0.2× 340 1.0× 61 1.3k
Mark B. Zimering United States 17 415 0.5× 222 0.5× 487 1.2× 176 0.5× 398 1.1× 57 1.3k
Thomas L. Cantor United States 14 893 1.1× 222 0.5× 342 0.8× 202 0.5× 213 0.6× 16 1.3k

Countries citing papers authored by Anya Rothenbühler

Since Specialization
Citations

This map shows the geographic impact of Anya Rothenbühler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anya Rothenbühler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anya Rothenbühler more than expected).

Fields of papers citing papers by Anya Rothenbühler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anya Rothenbühler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anya Rothenbühler. The network helps show where Anya Rothenbühler may publish in the future.

Co-authorship network of co-authors of Anya Rothenbühler

This figure shows the co-authorship network connecting the top 25 collaborators of Anya Rothenbühler. A scholar is included among the top collaborators of Anya Rothenbühler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anya Rothenbühler. Anya Rothenbühler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duplan, Martin Biosse, et al.. (2024). Orthodontic treatment in children and adolescent patients with X‐linked hypophosphatemia: A case–control study. Orthodontics and Craniofacial Research. 27(5). 697–703. 1 indexed citations
2.
Lecoq, Anne-Lise, Katharina Schilbach, L. Rocher, et al.. (2024). Metabolically healthy obesity in adults with X-linked hypophosphatemia. European Journal of Endocrinology. 191(2). 156–165. 3 indexed citations
3.
Dolci, Alessia, Anya Rothenbühler, Emanuele Ferrante, et al.. (2024). High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes. The Journal of Clinical Endocrinology & Metabolism. 110(5). 1334–1341.
4.
Zhukouskaya, Volha V., Andrew C. Ertl, Claire Bardet, et al.. (2023). Hyperparathyroidism after 3 years of burosumab in children affected with X-linked hypophosphatemia. Annales d Endocrinologie. 84(5). 544–544. 6 indexed citations
5.
Seefried, Lothar, Ali S. Alzahrani, Justine Bacchetta, et al.. (2023). XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH). Orphanet Journal of Rare Diseases. 18(S2). 333–333. 4 indexed citations
6.
Rothenbühler, Anya, Iva Gueorguieva, S. Soskin, et al.. (2023). Young XLH Patients-Reported Experience with a Supportive Care Program. Patient Preference and Adherence. Volume 17. 1393–1405. 2 indexed citations
7.
Nanclares, Guiomar Pérez de, Harald Jüppner, Patrick Hanna, et al.. (2023). Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations. European Journal of Endocrinology. 189(1). 123–131. 3 indexed citations
8.
Kamenický, Peter, Karine Briot, Volha V. Zhukouskaya, et al.. (2023). Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study. European Journal of Endocrinology. 189(4). 469–475. 4 indexed citations
9.
Fechtenbaum, J., Anya Rothenbühler, Peter Kamenický, et al.. (2023). Development of Spinal Enthesopathies in Adults With X-linked Hypophosphatemia. The Journal of Clinical Endocrinology & Metabolism. 108(12). e1524–e1531. 3 indexed citations
10.
Rothenbühler, Anya, et al.. (2023). Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 108(11). 2961–2969. 1 indexed citations
11.
Mantovani, Giovanna, Guiomar Pérez de Nanclares, Francesca Marta Elli, et al.. (2023). Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis. Journal of Endocrinological Investigation. 46(8). 1673–1684. 2 indexed citations
12.
Harambat, Jérôme, Anya Rothenbühler, Juliane Léger, et al.. (2022). Genotype-phenotype Description of Vitamin D–dependent Rickets 1A: CYP27B1 p.(Ala129Thr) Variant Induces a Milder Disease. The Journal of Clinical Endocrinology & Metabolism. 108(4). 812–826. 2 indexed citations
13.
Rothenbühler, Anya, et al.. (2022). Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia. JBMR Plus. 6(11). e10672–e10672. 21 indexed citations
14.
Linglart, Agnès, Aurélie Portefaix, Aurélia Bertholet‐Thomas, et al.. (2022). X-linked hypophosphatemia, obesity and arterial hypertension: data from the XLH21 study. Pediatric Nephrology. 38(3). 697–704. 6 indexed citations
15.
Lassalle, Louis, Catherine Chaussain, V. Merzoug, et al.. (2021). Prevalence of Enthesopathies in Adults With X-linked Hypophosphatemia: Analysis of Risk Factors. The Journal of Clinical Endocrinology & Metabolism. 107(1). e224–e235. 18 indexed citations
16.
Michot, Caroline, Geneviève Baujat, S. Baron, et al.. (2019). Pycnodysostosis: Natural history and management guidelines from 27 French cases and a literature review. Clinical Genetics. 96(4). 309–316. 31 indexed citations
17.
Lambert, Anne-Sophie, Volha V. Zhukouskaya, Anya Rothenbühler, & Agnès Linglart. (2018). L’hypophosphatémie liée à l’X : prise en charge et perspectives thérapeutiques. Revue du Rhumatisme Monographies. 86(1). 55–63.
18.
Linglart, Agnès, Martin Biosse Duplan, Karine Briot, et al.. (2014). Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocrine Connections. 3(1). R13–R30. 230 indexed citations
19.
Rothenbühler, Anya, et al.. (2011). A Pilot Study of Discontinuous, Insulin-Like Growth Factor 1–Dosing Growth Hormone Treatment in Young Children with FGFR3 N540K-Mutated Hypochondroplasia. The Journal of Pediatrics. 160(5). 849–853. 7 indexed citations
20.
Faucz, Fábio R., Anélia Horvath, Anya Rothenbühler, et al.. (2010). Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer. The Journal of Clinical Endocrinology & Metabolism. 96(1). E135–E140. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata C. Pereira Breakdown of academic impact, for papers by Peter Kamenický Breakdown of academic impact, for papers by Alison Skrinar Breakdown of academic impact, for papers by Takuo Kubota Breakdown of academic impact, for papers by Lars Rolighed Breakdown of academic impact, for papers by R Zahradnik Breakdown of academic impact, for papers by V. Braga Breakdown of academic impact, for papers by Ewa Lewin Breakdown of academic impact, for papers by Mark B. Zimering Breakdown of academic impact, for papers by Thomas L. Cantor
Rankless by CCL
2026